Expression of the human histocompatibility leukocyte antigen DR3 transgene reduces the severity of demyelination in a murine model of multiple sclerosis

Journal of Clinical Investigation

Volumn 101, Issue 8, 1998, Pages 1765-1774

  Drescher, Kristen M ^a   Nguyen, Loc T ^a   Taneja, Veena ^a   Coenen, Michael J ^a   Leibowitz, Julian L ^b   Strauss, Gundrun ^c   Hammerling, Gunter J ^c   David, Chella S ^a   Rodriguez, Moses ^a,d  

^a MAYO CLINIC   (United States)

^b TEXAS A AND M UNIVERSITY   (United States)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^d MAYO GRADUATE SCHOOL   (United States)

Author keywords

Demyelination; Theiler's virus

Indexed keywords

GAMMA INTERFERON; HLA DR3 ANTIGEN; INTERLEUKIN 4;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DEMYELINATION; MOUSE; MULTIPLE SCLEROSIS; MURINE ENCEPHALOMYELITIS VIRUS; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE;

EID: 0032522979     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI167     Document Type: Article

References (50)

1. Black, C., D. Briggs, and K. Welsh. 1992. The immunogenetic background of scleroderma - an overview. Clin. Exp. Dermatol. 17:73-78.
2. Pryhuber, K.G., K.J. Murray, P. Donnelly, M.H. Passo, W.P. Maksymowych, D.N. Glass, E.H. Giannini, and R.A. Colbert. 1996. Polymorphism in the LMP2 gene influences disease susceptibility and severity in HLA-B27 associated juvenile rheumatoid arthritis. J. Rheumatol. 23:747-752.
3. Zanelli, E., C.J. Krco, J.M. Baisch, S. Cheng, and C.S. David. 1996. Immune response of HLA-DQ8 transgenic mice to peptides from the third hyper-variable region of HLA-DRB1 correlates with predisposition to rheumatoid arthritis. Proc. Natl. Acad. Sci. USA. 93:1814-1819.
4. Zanelli, E., M.A. Gonzalez-Gay, and C.S. David. 1995. Could HLA-DRB1 be the protective locus in rheumatoid arthritis? Immunol. Today. 16: 274-278.
5. Fuks, A., S.J. Ono, E. Colle, and R.D. Guttmann. 1990. A single dose of the MHC-linked susceptibility determinant associated with the RT1u haplotype is permissive for insulin-dependent diabetes mellitus in the BB rat. Exp. Clin. Immunogenet. 7:162-169.
6. Stenszky, V., L. Kozma, C. Balazs, J.C. Bear, and N.R. Farid. 1986. The role of HLA antigens in the manifestation and course of Graves' disease. Mol. Biol. Med. 3:53-62.
7. Mustonen, J., J. Partanen, M. Kanerva, K. Pietila, O. Vapalahti, A. Pasternack, and N. Vaheri. 1996. Genetic susceptibility to severe course of nephropathia epidemica caused by Puumala hantavirus. Kid. Int. 49:217-221.
8. Simmons, A. H-2-linked genes influence the severity of herpes simplex virus infection of the peripheral nervous system. J. Exp. Med. 169:1503-1507.
9. Wolfgram, L.J., K.W. Beisel, A. Herskowitz, and N.R. Rose. 1986. Variations in the susceptibility of Coxsackievirus B3-induced myocarditis among different strains of mice. J. Immunol. 136:1846-1852.
10. Jersild, C., A. Svejgaard, and T. Fog. 1972. HLA antigens and multiple sclerosis. Lancet. i:1240-1242.
11. Ebers, G.C., K. Kukay, D.E. Bulman, A.D. Sadovnick, G. Rice, C. Anderson, H. Armstrong, K. Cousin, R.B. Bell, W. Hader, et al. 1996. A full genome screen in multiple sclerosis. Nat. Genet. 13:472-476.
12. Multiple Sclerosis Study Group. 1996. A complete genomic screen for multiple sclerosis underscores a role for the major histocompatibility complex. Nat. Genet. 13:469-471.
13. Sawcer, S., H.B. Jones, R. Feakes, J. Gray, N. Smaldon, J. Chataway, N. Robertson, D. Clayton, P.N. Goodfellow, and A. Compston. 1996. A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22. Nut. Genet. 13:464-468.
14. Ebers, G.C., and A.D. Sadovnick. 1994. Association studies in multiple sclerosis. J. Neuroimmunol. 53:117-122.
15. Duquette, P., F. Decary, J. Pleines, D. Boivin, G. Lamoureux, J.B. Cosgrove, and Y. Lapierre. 1985. Clinical sub-groups of multiple sclerosis in relation to HLA: DR alleles as possible markers of disease progression. Can. J. Neurol. Sci. 12:106-110.
16. Engell, T., N.E. Raun, M. Thomsen, and P. Platz. 1982. HLA and heterogeneity of multiple sclerosis. Neurology. 32:1043-1046.
17. Poser, S., G. Ritter, H.J. Bauer, H. Grosse-Wilde, E.K. Kuwert, and N.E. Raun. 1981. HLA antigens and the prognosis of multiple sclerosis. J. Neurol. 225:219-221.
18. British and Dutch Multiple Sclerosis Azathioprine Trial Group. 1988. Histocompatibility antigens in multiple sclerosis patients participating in a multicentre trial of azathioprine. J. Neurol. Neurosurg. Psychiatry. 51:412-415.
19. Runmarker, B., T. Martinsson, J. Wahlstrom, and O. Andersen. 1994. HLA and prognosis in multiple sclerosis. J. Immunol. 241:385-390.
20. Lipton, H.L. 1975. Theiler's virus infection in mice: an unusual biphasic disease leading to demyelination. Infect. Immun. 11:1147-1155.
21. Rodriguez, M., J.L. Leibowitz, and C.S. David. 1986. Susceptibility to Theiler's virus-induced demyelination. Mapping of the gene within the H-2D region. J. Exp. Med. 163:620-631.
22. Clatch, R.J., R.W. Melvoid, S.D. Miller, and H.L. Lipton. 1985. Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease is influenced by the H-2D region: correlation with TMEV-specific delayed-type hypersensitivity. J. Immunol. 135:1408-1414.
23. Rodriguez. M., and C.S. David. 1985. Demyelination induced by Theiler's virus: influence of the H-2 haplotype. J. Immunol. 135:2145-2148.
24. Melvoid, R.W., D.M. Jokinen, S.D. Miller, M.C. Dal Canto, and H.L. Lipton. 1987. H-2 genes in TMEV-induced demyelination, a model for multiple sclerosis. In Major Histocompatibility Genes and Their Role in Immune Function. C. David, editor. Plenum Publishing Corp., New York. 735-745.
25. Patick, A.K., L.R. Pease, C.S. David, and M. Rodriguez. 1990. Major histocompalibility complex-conferred resistance to Theiler's virus-induced demyelinating disease is inherited as a dominant trait in B10 congenic mice. J. Virol. 64:5570-5576.
26. Rodriguez, M., C.S. David, and L.R. Pease. 1987. The contribution of MHC gene products to demyelination by Theiler's virus. In Major Histocompatibility Genes and Their Role in Immune Function. C. David, editor. Plenum Publishing Corp., New York. 747-756.
27. Rodriguez, M., W.P. Lafuse, J.L. Leibowitz, and C.S. David. 1986. Partial suppression of Theiler's virus-induced demyelination in vivo by administration of monoclonal antibodies to immune-response gene products (Ia antigens). Neurology. 36:964-970.
28. Rodriguez, M., and S. Sriram. 1988. Successful therapy of TMEV-induced demyelination (DA strain) with monoclonal anti-lyt 2.2 antibody. J. Immunol. 140:2950-2955.
29. Welsh, C.J., P. Tonks, A.A. Nash, and W.F. Blakemore. 1987. The effect of L3T4 T cell depletion on the pathogenesis of Theiler's murine encephalomyelitis virus infection in CBA mice. J. Gen. Virol. 68:1659-1667.
30. Njenga, M.K., K.D. Pavelko, J. Baisch, X. Lin, C.S. David, J.L. Leibowitz, and M. Rodriguez. 1996. Theiler's virus persistence and demyelination in major histocompatibility complex class II-deficient mice. J. Virol. 70:1729-1737.
31. Rodriguez, M., M.L. Pierce, and E.A. Howie. 1987. Immune response gene products (Ia antigens) on glial and endothelial cells in virus-induced demyelination. J. Immunol. 138:3438-3442.
32. Strauss, G., D.A.A. Vignali, G. Schonrich, and G.L. Hammerling. 1994. Negative and positive selection by HLA-DR3(DRw17) molecules in transgenic mice. Immunogenetics. 40:104-108.
33. Pierce, M., and M. Rodriguez. 1989. Erichrome stain for myelin on osmicated tissue embedded in glycol methacrylate plastic. J. Histotechnol. 12:35-36.
34. Rodriguez, M., J.L. Leibowitz, H.C. Powell, and P.W. Lampert. 1984. Neonatal infection with the DA strain of Theiler's murine encephalomyelitis virus (TMEV). Lab. Invest. 49:672-679.
35. b mice deficient in β2-microglobulin. J. Immunol. 151:266-276.
36. Miller, D.J., M.K. Njenga, P.D. Murray, J.L. Leibowitz, and M. Rodriguez. 1996. A monoclonal natural autoantibody that promotes remyelination suppresses central nervous system inflammation and increases virus expression after Theiler's virus-induced demyelination. Int. Immunol. 8:131-141.
37. Krco, C.J., T.G. Beito, and C.S. David. 1992. Determination of tolerance to self E alpha peptides by clonal elimination of H-2E reactive T cells and antigen presentation by H-2A molecules. Transplantation (Baltimore). 54:920-923.
38. Lindsley, M., and M. Rodriguez. 1989. Characterization of the inflammatory response in the CNS of mice susceptible or resistant to demyelination by Theiler's virus. J. Immunol. 142:2677-2682.
39. Rodriguez, M., J.J. Kenny, R.L. Thiemann, and G.E. Woloschak. 1990. Theiler's virus-induced demyelination in mice immunosuppressed with anti-IgM and in mice expressing the xid gene. Microb. Pathg. 8:23-35.
40. Rodriguez, M., G.H. Nabozny, R.L. Thiemann, and C.S. David. 1994. Influence of deletion of T cell receptor V́ genes on Theiler's virus model of multiple sclerosis. Autoimmunity. 19:221-230.
41. Rodriguez, M., A.K. Patick, L.R. Pease, and C.S. David. 1992. Role of T cell receptor Vβ genes in Theiler's virus-induced demyelination of mice. J. Immunol. 148:921-927.
42. Kong, Y.C.M., L.C. Lomo, R.W. Motte, A.A. Giraldo, J. Baisch, G. Strauss, G.J. Hammerling, and C.S. David. 1996. HLA-DRB1 polymorphism determines susceptibility to autoimmune thyroiditis in transgenic mice: definitive association with HLA-DRB1*0301 (DR3) gene. J. Exp. Med. 184:1167-1172.
43. Locksley, R.M., and J.A. Louis. 1992. Immunology of leishmaniasis. Curr. Opin. Immunol. 4:413-418.
44. Sher, A., R.T. Gazzinelli, I.P. Oswald, M. Clerici, M. Kullberg, E.J. Pearce, J.A. Berzofsky, T.R. Mosmann, S.L. James, and H.C. Morse III. 1992. Role of T-cell derived cytokines in the downregulation of immune responses in parasitic and retroviral infection. Immunol. Rev. 127:183-204.
45. Munk, M.E., and M. Emoto. 1995. Functions of T-cell subsets and cytokines in mycobacterial infections. Eur. Resp. J. Suppl. 20:668S-675S.
46. Paya, C.V., P.J. Leibson, A.K. Patick, and M. Rodriguez. 1990. Inhibition of Theiler's virus-induced demyelination in vivo by tumor necrosis factor alpha. Im. Immunol. 2:909-913.
47. Rodriguez, M., K.D. Pavelko, C.W. McKinney, and J.L. Leibowitz. 1994. Recombinant human IL-6 suppresses demyelination in a viral model of multiple sclerosis. J. Immunol. 153:3811-3821.
48. Pullen, L.C., S.D. Miller, M.C. Dal Canto, P.M. Van der Meide, and B.S. Kim. 1994. Alteration in the level of interferon-gamma results in acceleration of Theiler's virus-induced demyelinating disease. J. Neuroimmunol. 55:143-152.
49. Gerety, S.J., M.K. Rundell, M.C. Dal Canto, and S.D. Miller. 1994. Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus-induced demyelinating disease. V. Mapping of a dominant immunopathologic VP2 T cell epitope in susceptible SJL/J mice. J. Immunol. 152:908-918.
50. Gerety, S.J., M.K. Rundell, M.C. Dal Canto, and S.D. Miller. 1994. Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus-induced demyelinating disease. VI. Potentiation of demyelination with and characterization of an immunopathologic CD4+ T cell line specific for an immunodominant VP2 epilope. J. Immunol. 152:919-929.